(MOUNTAIN VIEW, Calif.)Alexza Pharmaceuticals said Tuesday its experimental drug significantly reduced symptoms of schizophrenia in a late-stage trial. The company reported that a study of 344 schizophre...READ MORE
Among the earnings stories for Monday, May 12, from AP Financial News: McLEAN, Va. (AP) _ BearingPoint Inc., a management and technology consultant, said Monday its first-quarter l...READ MORE
(MOUNTAIN VIEW, Calif.)Drug developer Alexza Pharmaceuticals Inc. said Monday that its first-quarter loss widened on increased research and development spending. The company lost $14.6 million, or 47 cen...READ MORE
Among the stock activity stories for Tuesday, March 18, from AP Financial News: NEW YORK (AP) _ Shares of biotechnology company Genzyme Corp. are rising after the company reaffirme...READ MORE
(NEW YORK)Alexza Pharmaceuticals Inc. shares fell, and reached an all-time low amid concerns that the company lacks the funds needed to develop its drug candidates.READ MORE
(NEW YORK)An RBC Capital Markets analyst said Friday that a deal between Alexza Pharmaceuticals Inc. and Endo Pharmaceuticals Holdings Inc. is "extremely valuable" for Alexza because of Endo...READ MORE